Jonathan Alicea

Exciting Advances Are Coming for First-line CML Treatment

August 10, 2017

Kendra Sweet, M.D., discussed the various factors that must be taken into account when prescribing first-line therapies to patients with CML, the novel studies that are paving the way for improved outcomes in patients, and the increasing likelihood for TKI discontinuation on the horizon.